Dicot Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:DICOT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Nov 24	BuySEK 57,859	Eva Saers	Individual	243,210	SEK 0.24
25 Sep 24	BuySEK 50,784	Eva Saers	Individual	320,000	SEK 0.16
24 Sep 24	BuySEK 32,841	Eva Saers	Individual	200,000	SEK 0.16

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DICOT?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	106,593,644	5.3%
Individual Insiders	182,417,735	9.08%
Institutions	247,228,319	12.3%
General Public	1,473,102,804	73.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 145.8%.

Top Shareholders

Top 16 shareholders own 27.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.03%	Avanza Fonder AB	181,479,622	SEK 69.0m	102%	0.05%
6.72%	Bertil Lindkvist	135,034,098	SEK 51.3m	100%	no data
3.01%	Nordnet Pensionsförsäkring Ab, Asset Management Arm	60,464,769	SEK 23.0m	179%	0.34%
2.84%	Tor Finans Ab	57,000,000	SEK 21.7m	0%	no data
1.39%	Skyddsprodukter I Sverige Finans Ab	28,000,000	SEK 10.6m	0%	no data
0.91%	Klas Strömberg	18,296,000	SEK 7.0m	103%	no data
0.77%	Swedbank Försäkring AB, Asset Management Arm	15,503,451	SEK 5.9m	0%	1.21%
0.76%	Aktiebolaget Syoto	15,200,000	SEK 5.8m	0%	no data
0.51%	Michael Zell	10,225,000	SEK 3.9m	-37.5%	no data
0.49%	Kenneth Sjökvist	9,882,746	SEK 3.8m	0%	no data
0.33%	Gunilla Paalberg	6,598,202	SEK 2.5m	0%	no data
0.32%	Gryningskust FÖRvaltning Ab	6,393,644	SEK 2.4m	0%	no data
0.041%	Eva Saers	823,407	SEK 312.9k	41.9%	no data
0.033%	Elin Trampe	655,000	SEK 248.9k	0%	no data
0.03%	Per-Goran Gillberg	600,000	SEK 228.0k	0%	no data
0.015%	Charlotta Gauffin	303,282	SEK 115.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/13 05:41
End of Day Share Price	2025/05/13 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dicot Pharma AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.